United States · FDA National Drug Code directory

Trikafta

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 51167-331_b63ac090-8d8b-43a0-82d1-558127f2d598
Product NDC: 51167-331
Form: KIT
Composition / generic term: Elexacaftor, Tezacaftor, and Ivacaftor
Labeler: Vertex Pharmaceuticals Incorporated
Marketing category: NDA
Marketing start / end (source format): 20191021
Source listing expiry: 20271231

Source-listed ingredients

Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.

These values do not establish equivalence or a dose recommendation.

Packages

4 BLISTER PACK in 1 CARTON (51167-331-01) / 1 KIT in 1 BLISTER PACK * 14 TABLET, FILM COATED in 1 BLISTER PACK (51167-431-14) * 7 TABLET, FILM COATED in 1 BLISTER PACK (51167-531-07) · 51167-331-01

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →